TerryLynnEvansMD

PubMed

• Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.
  Lujia Chen, Ying Wang, Chunhui Cai, Ying Ding, Rim S Kim, Corey Lipchik, Patrick G Gavin, Greg Yothers, Carmen J Allegra, Nicholas J Petrelli, Jennifer Marie Suga, Jud...> ;Journal of Clinical Oncology. 2024 Feb 5
• 3 citations
  Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04.
  Patricia A Ganz, Ron D Hays, Karen L Spritzer, André Rogatko, Clifford Y Ko, Linda H Colangelo, Amit Arora, Judith O Hopkins, Terry L Evans, Greg Yothers> ;Cancer. 2022 Sep 1
• 36 citations
  Phase III randomized study of 4 weeks of high-dose interferon-α-2b in stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) melanoma: A trial of the Eastern Coop...
  Sanjiv S. Agarwala, Sandra J. Lee, Wai-Ki Yip, Uma N. M. Rao, Ahmad A. Tarhini, Gary I. Cohen, Douglas S. Reintgen, Terry L. Evans, Joanna M. Brell, Mark R. Albertini,...> ;Journal of Clinical Oncology. 2017 Jan 30
• 14 citations
  Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer
  Suresh S. Ramalingam, Judy Foster, William Gooding, Terry Evans, M. Sulecki, Chandra P. Belani> ;Cancer. 2010 Mar 1
• 26 citations
  Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer
  Joanna M. Brell, Khalid Matin, Terry Evans, Robert Volkin, Gauri J. Kiefer, James J. Schlesselman, S. Dranko, Linda Rath, Amy Schmotzer, Diana Lenzner, Ramesh K. Raman...> ;Oncology. 2009 Jan 1
• 71 citations
  Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.
  Samuel A. Jacobs, Steven H. Swerdlow, Jeffrey A. Kant, Kenneth A. Foon, Rachel C. Jankowitz, Stephanie R. Land, Nicholas A. DeMonaco, Judith M. Joyce, Jennifer L. Osbo...> ;Clinical Cancer Research. 2008 Nov 1
• Oxaliplatin and docetaxel in castration-resistant prostate cancer (CRPC) patients treated with up to two prior chemotherapeutic regimens: Updated results of a phase II...
  Chatta GS, Feinstein TM, Appleman LJ, Friedland DM, Jacobs SA, Evans TL, Earle MF, Strausser HM, Gooding WE, Lenzner D> ;J. Clin. Oncol.. 2008-05-20
• 42 citations
  Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refra...
  Suresh Ramalingam, Judy Forster, C. L. Naret, Terry Evans, Matt Sulecki, Haolan Lu, Paola Teegarden, Martin R. Weber, Chandra P. Belani> ;Journal of Thoracic Oncology. 2008 Mar 1
• Imaging results after CHOP-rituximab followed by 90Y ibritumomab tiuxetan and rituximab (R) in patients with previously-untreated follicular lymphoma (FL).
  Demonaco NA, Wu M, Osborn J, Evans T, Foon KA, Swerdlow S, Kant J, Joyce J, Land S, Jacobs SA> ;J. Clin. Oncol.. 2006-06-20
• Phase II study of volociximab (M200), an α5β1 anti-integrin antibody in metastatic adenocarcinoma of the pancreas (MPC).
  Valle JW, Ramanathan RK, Glynne-Jones R, Anthoney A, Berlin J, Yazji S, Evans T> ;J. Clin. Oncol.. 2006-06-20
• Phase II study of gefitinib and docetaxel as salvage therapy in patients (pts) with advanced pancreatic adenocarcinoma (APC).
  Shadad F, Matin K, Evans TL, Volkin RL, Kiefer GJ, Schlesselman JJ, Cai C, Schmotzer A, Dranko S, Ramanathan RK> ;J. Clin. Oncol.. 2006-06-20
• 4 citations
  A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer
  Khalid Matin, Samuel A. Jacobs, Thomas J. Richards, Michael Ka Keu Wong, Martin Earle, Terry Evans, Monica Troetschel, William Ferri, David M. Friedland, R. A. Pinkert...> ;American Journal of Clinical Oncology. 2005 Oct 1
• 104 citations
  Low Overexpression of HER-2/Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial
  Ramesh K. Ramanathan, Jimmy J. Hwang, William C. Zamboni, Frank A. Sinicrope, Howard Safran, Michael Ka Keu Wong, Martin Earle, Adam Brufsky, Terry Evans, Monica Troet...> ;Cancer Investigation. 2004 Nov 23
• Phase I/II study of trimetrexate (TMTX) and capecitabine (CAP) as second and third- line therapy in patients with advanced colorectal cancer (CRC).
  Matin K, Ramanathan RK, Jacobs SA, Wong MK, Earle M, Evans T, Troetschel M, Ferri W, Friedland D, Wieand S> ;J. Clin. Oncol.. 2004-07-15
• 26 citations
  Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients.
  Ramesh K. Ramanathan, Douglas M. Potter, Chandra P. Belani, Samuel A. Jacobs, Stefan Gravenstein, Felix Lim, Hyoung D. Kim, Steven Savona, Terry Evans, Dianne Buchbark...> ;Journal of Clinical Oncology. 2002 Nov 1
• 12 citations
  Thrombotic thrombocytopenic purpura: clinical course and response to therapy in eight patients.
  Terry L. Evans, Alan Winkelstein, Zella R. Zeigler, Richard K. Shadduck, Kenneth F. Mangan> ;American Journal of Hematology. 1984 Dec 1
• Join now to see all